A Glimpse Into The Expert Outlook On Medpace Hldgs Through 6 Analysts
Portfolio Pulse from Benzinga Insights
Analysts have provided mixed ratings for Medpace Holdings (NASDAQ: MEDP) over the past three months, with a majority being bullish. The average 12-month price target has increased by 5.58% to $446.33. Analysts from firms like Mizuho, Guggenheim, Baird, Jefferies, Deutsche Bank, and UBS have updated their ratings and price targets, reflecting positive sentiment towards the company's financial performance.
May 28, 2024 | 12:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts have shown a predominantly bullish outlook on Medpace Holdings, with the average 12-month price target increasing by 5.58% to $446.33. This reflects positive sentiment towards the company's financial performance and growth prospects.
The majority of analysts have given bullish ratings, and the average price target has increased, indicating positive sentiment towards Medpace Holdings. This is likely to have a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100